Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28751 - 28775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	TK2	7084	downregulated	Cytarabine results in decreased expression of TK2 mRNA	16q21	A21888
Cytarabine	Approved Investigational	TLN2	83660	downregulated	Cytarabine results in decreased expression of TLN2 mRNA	15q22.2	A21886
Cytarabine	Approved Investigational	TMED1	11018	downregulated	Cytarabine results in decreased expression of TMED1 mRNA	19p13.2	A21886
Cytarabine	Approved Investigational	TMED9	54732	downregulated	Cytarabine results in decreased expression of TMED9 mRNA	5q35.3	A21886
Cytarabine	Approved Investigational	TMEM200A	114801	downregulated	Cytarabine results in decreased expression of TMEM200A mRNA	6q23.1	A21886
Cytarabine	Approved Investigational	TMEM45A	55076	downregulated	Cytarabine results in decreased expression of TMEM45A mRNA	3q12.2	A21886
Cytarabine	Approved Investigational	TMEM62	80021	upregulated	Cytarabine results in increased expression of TMEM62 mRNA	15q15.2	A21886
Cytarabine	Approved Investigational	TMEM88	92162	downregulated	Cytarabine results in decreased expression of TMEM88 mRNA	17p13.1	A21886
Cytarabine	Approved Investigational	TMEM98	26022	downregulated	Cytarabine results in decreased expression of TMEM98 mRNA	17q11.2	A21886
Cytarabine	Approved Investigational	TMSB15B	286527	upregulated	Cytarabine results in increased expression of TMSB15B mRNA	Xq22.2	A21886
Cytarabine	Approved Investigational	TNFAIP3	7128	downregulated	Cytarabine results in decreased expression of TNFAIP3 mRNA	6q23.3	A21886
Cytarabine	Approved Investigational	TNFSF10	8743	upregulated	Cytarabine results in increased expression of TNFSF10 mRNA	3q26	A20985
Cytarabine	Approved Investigational	TNNT2	7139	downregulated	Cytarabine results in decreased expression of TNNT2 mRNA	1q32.1	A21886
Cytarabine	Approved Investigational	TNRC6A	27327	upregulated	Cytarabine results in increased expression of TNRC6A mRNA	16p12.1	A21886
Cytarabine	Approved Investigational	TPK1	27010	downregulated	Cytarabine results in decreased expression of TPK1 mRNA	7q35	A21886
Cytarabine	Approved Investigational	TPST1	8460	downregulated	Cytarabine results in decreased expression of TPST1 mRNA	7q11.21	A21886
Cytarabine	Approved Investigational	TRGV9	6983	upregulated	Cytarabine results in increased expression of TRGV9 mRNA	7p14.1	A20985
Cytarabine	Approved Investigational	TRIM5	85363	downregulated	Cytarabine results in decreased expression of TRIM5 mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	TRIM6	117854	downregulated	Cytarabine results in decreased expression of TRIM6 mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	TRPV2	51393	downregulated	Cytarabine results in decreased expression of TRPV2 mRNA	17p11.2	A21886
Cytarabine	Approved Investigational	TSPAN4	7106	downregulated	Cytarabine results in decreased expression of TSPAN4 mRNA	11p15.5	A21886
Cytarabine	Approved Investigational	TSPO	706	downregulated	Cytarabine results in decreased expression of TSPO mRNA	22q13.2	A21886
Cytarabine	Approved Investigational	TST	7263	downregulated	Cytarabine results in decreased expression of TST mRNA	22q12.3	A21886
Cytarabine	Approved Investigational	TTYH1	57348	upregulated	Cytarabine results in increased expression of TTYH1 mRNA	19q13.42	A21886
Cytarabine	Approved Investigational	U2AF1	7307	downregulated	Cytarabine results in decreased expression of U2AF1 mRNA	21q22.3	A21886

Displaying entries 28751 - 28775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability